The Ministry of Well being will current its plan to fight dengue fever in 2025 in September this yr, with measures specializing in environmental management methods, epidemiological surveillance and care of probably the most extreme instances of the illness.
There may be nonetheless no clear definition for increasing dengue vaccination protection. At the moment, the vaccine is just obtainable to kids and adolescents aged 10 to 14 years. The vaccine is allowed by the Nationwide Well being Supervision Company (Anvisa) and is appropriate for individuals aged 4 to 60 years previous.
Additionally learn Well being Butantan’s dengue vaccine stays efficient in 3.7 years. Loss Brazil’s Well being Directorate recommends states broaden dengue vaccination protection. perceive
Well being Minister Nísia Trindade defined that mass vaccination shouldn’t be but a possible technique as a result of the producer – Takeda Laboratories – has manufacturing difficulties. “Vaccines are a technique that we are going to proceed to make use of, however it isn’t the principle technique in 2025. It might be the principle technique in 2026, relying on the event of the butantan vaccine,” Trindade mentioned at a breakfast assembly with reporters on Wednesday. (28/8).
Takeda and Butantan
One chance for increasing vaccine provide is a know-how switch settlement,